U.S. flag

An official website of the United States government

Display Settings:

Format
Sort by

Send to:

Choose Destination

Links from Books

Items: 4

1.
Palbociclib: A Novel Cyclin-Dependent Kinase Inhibitor for Hormone Receptor–Positive Advanced Breast Cancer
Neha S. Mangini, Robert Wesolowski, Bhuvaneswari Ramaswamy, Maryam B. Lustberg, Michael J. Berger
Ann Pharmacother. Author manuscript; available in PMC 2020 Jul 2.
Published in final edited form as: Ann Pharmacother. 2015 Nov; 49(11): 1252–1260. Published online 2015 Aug 31. doi: 10.1177/1060028015602273
PMCID:
PMC7331461
AbstractArticlePDF–481K
2.
Palbociclib-Induced Liver Failure
Rami Atallah, Nathaniel A. Parker, Karl Hamouche, Quoc V. Truong, Megan Dingwall
Kans J Med. 2020; 13: 81–82. Published online 2020 Apr 17.
PMCID:
PMC7182058
ArticlePDF–253K
3.
Management of Adverse Events Due to Cyclin-Dependent Kinase 4/6 Inhibitors
Johannes Ettl
Breast Care (Basel) 2019 Apr; 14(2): 86–92. Published online 2019 Mar 28. doi: 10.1159/000499534
Correction in:
Breast Care (Basel). 2020 Feb; 15(1): 102.
PMCID:
PMC6886109
AbstractArticlePDF–692K
4.
Phase II Trial of the CDK4 Inhibitor PD0332991 in Patients With Advanced CDK4-Amplified Well-Differentiated or Dedifferentiated Liposarcoma
Mark A. Dickson, William D. Tap, Mary Louise Keohan, Sandra P. D'Angelo, Mrinal M. Gounder, Cristina R. Antonescu, Jonathan Landa, Li-Xuan Qin, Dustin D. Rathbone, Mercedes M. Condy, Yelena Ustoyev, Aimee M. Crago, Samuel Singer, Gary K. Schwartz
J Clin Oncol. 2013 Jun 1; 31(16): 2024–2028. Published online 2013 Apr 8. doi: 10.1200/JCO.2012.46.5476
PMCID:
PMC3661937
AbstractArticlePDF–641K

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center